Skip to main content

Advertisement

Log in

Polyoxypregnane glycoside from Dregea volubilis extract inhibits IL-1β-induced expression of matrix metalloproteinase via activation of NF-κB in human chondrocytes

  • Published:
In Vitro Cellular & Developmental Biology - Animal Aims and scope Submit manuscript

Abstract

Interleukin-1β (IL-1β) induces the expression of matrix metalloproteinases (MMPs) implicated in cartilage and joint degradation in osteoarthritis (OA) and rheumatoid arthritis (RA). Polyoxypregnane glycoside (PPG), active compound was identified from Dregea volubilis extract by chemical analysis, shown to exert chondroprotective effects in cartilage explant models. However, no studies have been undertaken for the molecular investigation of whether PPG constituents protect the human articular chondrocyte (HAC). In the present studies, HAC was co-treated with IL-1β and PPG. The expression of MMPs, type II collagen, phosphorylation of mitogen-activated protein kinases (MAPKs) and NF-κB signaling pathway were determined by Western immunoblotting. PPG (6.25–25 μM) decreased the IL-1β-induced HA release from chondrocyte to culture medium. The mode of action of PPG was likely mediated through inhibiting expression of MMP-1, -3 and -13 in the medium, which was associated with the inhibition of mRNA expression. PPG had no effect on IL-1β-induced phosphorylation of MAPK pathway. Conversely, PPG decreased phosphorylation of IκB kinase and IκBα degradation. Taken together, these results indicate that PPG may inhibit cartilage degradation in OA and may also be used as nutritional supplement for maintaining joint integrity and function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1.
Figure 2.
Figure 3.
Figure 4.
Figure 5.
Figure 6.
Figure 7.
Figure 8.

Similar content being viewed by others

References

  • Berenbaum F. Signaling transduction: target in osteoarthritis. Curr. Opin. Rheumatol. 16: 616–622; 2004.

    Article  PubMed  Google Scholar 

  • Brandt K. Definition of osteoarthritis. In: Diagnosis and nonsurgical management of osteoarthritis. pp 17–19; 2000.

  • Brinkerhoff C. E.; Matrisian L. M. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell. Biol. 3: 207–214; 2002.

    Google Scholar 

  • Burrage P. S.; Mix K. S.; Brinckerhoff C. E. Matrix metalloproteinases: role in arthritis. Front. Biosci. 11: 529–453; 2006.

    Google Scholar 

  • Dean D. D.; Martel-Pelletier J.; Pelletier J. P.; Howell D. S.; Woessner Jr. J. F. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J. Clin. Invest. 84: 678–685; 1989.

    Article  PubMed  CAS  Google Scholar 

  • Fenton J. I.; Chlebek-Brown K. A.; Peters T. L.; Caron J. P.; Orth M. W. Glucosamine HCl reduces equine articular cartilage degradation in explant culture. Osteoarthr. Cartil. 8: 258–265; 2000.

    Article  PubMed  CAS  Google Scholar 

  • Fernandes J. C.; Martel-Pelletier J.; Pelletier J. P. The role of cytokines in osteoarthritis pathophysiology. Biorheology. 39: 237–246; 2002.

    Google Scholar 

  • Flannery C. R.; Little C. B.; Hughes C. E.; Caterson B. Expression and activity of articular cartilage hyaluronidases. Biochem. Biophys. Res. Commun. 251: 824–829; 1998.

    Article  PubMed  CAS  Google Scholar 

  • Kim K. S.; Choi H. M.; Bang J. S.; Ryu C. J.; Kim J. H.; Yoo M. C.; Yang H. I. Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes. Eur. J. Pharmacol. 613: 167–175; 2009.

    Article  PubMed  CAS  Google Scholar 

  • Kirkham B. Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis. Ann. Rheum. Dis. 50: 395–400; 1991.

    Article  PubMed  CAS  Google Scholar 

  • Knauper V.; Lopez-Otin C.; Smith B.; Knight G.; Murphy G. Biochemical characterization of human collagenase-3. J. Biol. Chem. 271: 1544–1550; 1996.

    Article  PubMed  CAS  Google Scholar 

  • Kongtawelert P.; Ghosh P. An enzyme-linked immunosorbent-inhibition assay for quantitation of hyaluronan (hyaluronic acid) in biological fluids. Anal. Biochem. 178: 367–372; 1989.

    Article  PubMed  CAS  Google Scholar 

  • Konttinen Y. T.; Ceponis A.; Takagi M.; Ainola M.; Sorsa T.; Sutinen M.; Salo T.; Ma J.; Santavirta S.; Seiki M. New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol. 17: 585–601; 1998.

    Article  PubMed  CAS  Google Scholar 

  • Koskinen A.; Vuolteenaho K.; Nieminen R.; Moilanen T.; Moilanen E. Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients. Clin. Exp. Rheumatol. 29: 57–64; 2011.

    PubMed  Google Scholar 

  • Laurent T. C. Hyaluronan as a clinical marker of pathological processes: in the chemistry, biology and medical applications of hyaluronan and its derivatives. 72: 305–313; 1998.

  • Little C. B.; Flannery C. R.; Hughes C. E.; Mort J. S.; Roughley P. J.; Dent C.; Caterson B. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem. J. 344: 61–68; 1999.

    Article  PubMed  CAS  Google Scholar 

  • Liu F. C.; Hung L. F.; Wu W. L.; Chang D. M.; Huang C. Y.; Lai J. H.; Ho L. J. Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes. Arthritis Res. Ther. 12: R167; 2010.

    Article  PubMed  Google Scholar 

  • Livak K. J.; Schmittgen T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-deltaCt method. Methods 25: 402–408; 2001.

    Article  PubMed  CAS  Google Scholar 

  • Lotz M. Cytokines in cartilage injury and repair. Clin. Orthop. 391: 108–115; 2001.

    Article  Google Scholar 

  • Loyau G.; Pujol J. P. The role of cytokines in the development of osteoarthritis. Scand. J. Rheumatol. Suppl. 81: 8–12; 1990.

    Article  PubMed  CAS  Google Scholar 

  • Mengshol J. A.; Vincenti M. P.; Coon C. I.; Barchowsky A.; Brinkerhoff C. E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase-13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase and nuclear factor kappaB. Differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 43: 801–811; 2000.

    Article  PubMed  CAS  Google Scholar 

  • Mitchell P. G.; Magna H. A.; Reeves L. M.; Lopresti-Morrow L. L.; Yocum S. A.; Rosner P. J.; Geoghegan K. F.; Hambor J. E. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97: 761–768; 1996.

    Article  PubMed  CAS  Google Scholar 

  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55–63; 1983.

    Article  PubMed  CAS  Google Scholar 

  • Panda N.; Mandal N. B.; Banerjee S.; Sahu N. P.; Koike K.; Nikaido T.; Weber M.; Luger P. Polyhydroxy pregnanes from Dregea volubilis. Tetrahedron 59: 8399–8403; 2003.

    Article  CAS  Google Scholar 

  • Piecky M.; Anderson P. Signal transduction in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 15: 789–803; 2001.

    Article  Google Scholar 

  • Robbins J. R.; Thomas B.; Tan L.; Choy B.; Arbiser J. L. Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1beta. Arthritis Rheum. 43: 2189–2201; 2000.

    Google Scholar 

  • Roman-Blas J. A.; Jimenez S. A. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthr. Cartil. 14: 839–848; 2006.

    Article  PubMed  CAS  Google Scholar 

  • Sampson P. M.; Rochester C. L.; Freundlich B.; Elias J. A. Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. J. Clin. Invest. 90: 1492–1503; 1992.

    Article  PubMed  CAS  Google Scholar 

  • Sangha O. Epidemiology of rheumatic diseases. Rheumatology 39: 3–12; 2000.

    PubMed  Google Scholar 

  • Sanyacharernkul S.; Itthiarbha A.; Kongtawelert P.; Meepowpan P.; Nuntasaen N.; Pompimon W. A New Polyoxypregnane Glycoside from the Roots of Dregea volubilis (L.f) Benth. ex Hook. f and its Chondroprotective Effect. Am. J. Biochem. Biotechnol. 5: 202–209; 2009.

    Article  CAS  Google Scholar 

  • Shlopov B. V.; Gumanovskaya M. L.; Hasty K. A. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis. Arthritis Rheum. 43: 195–205; 2000.

    Article  PubMed  CAS  Google Scholar 

  • Sinkov V.; Cymet T. Osteoarthritis: understanding the pathophysiology, genetics, and treatments. J. Natl Med. Assoc. 95: 475–482; 2003.

    PubMed  Google Scholar 

  • Tachakittirungrod S.; Okonogi S.; Chowwanapoonpohn S. Study on antioxidant activity of certain plants in Thailand: Mechanism of antioxidant action of guava leaf extract. Food Chem. 103: 381–388; 2007.

    Article  CAS  Google Scholar 

  • Tetlow L. C.; Adlam D. J.; Woolley D. E. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenera- tive changes. Arthritis Rheum. 44: 585–594; 2001.

    Article  PubMed  CAS  Google Scholar 

  • Tew S. R.; Hardingham T. E. Regulation of SOX9 mRNA in human articular chondrocytes involving p38 MAPK activation and mRNA stabilization. J. Biol. Chem. 281: 39471–39479; 2006.

    Article  PubMed  CAS  Google Scholar 

  • Vankemmelbeke M.; Dekeyser P. M.; Hollander A. P.; Buttle D. J.; Demeester J. Characterization of helical cleavages in type II collagen generated by matrixins. Biochem. J. 330: 633–640; 1998.

    PubMed  CAS  Google Scholar 

  • Vincenti M. P.; Brinkerhoff C. E. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 4: 157–164; 2002.

    Article  PubMed  CAS  Google Scholar 

  • Visse R.; Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function and biochemistry. Circ. Res. 92: 827–839; 2003.

    Article  PubMed  CAS  Google Scholar 

  • Wood D. D.; Ihrie E. J.; Dinarello C. A.; Cohen P. L. Isolation of an interleukin-1-like factor from human joint effusions. Arthritis. Rheum. 26: 975–983; 1983.

    Google Scholar 

Download references

Acknowledgment

The authors would like to acknowledge financial support from the Thailand Excellence Centre for Tissue Engineering and Stem Cells, Department of Biochemistry, Faculty of Medicine, Chiang Mai University and Chiang Mai Graduate School for the financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Prachya Kongtawelert.

Additional information

Editor: T. Okamoto

Rights and permissions

Reprints and permissions

About this article

Cite this article

Itthiarbha, A., Phitak, T., Sanyacharernkul, S. et al. Polyoxypregnane glycoside from Dregea volubilis extract inhibits IL-1β-induced expression of matrix metalloproteinase via activation of NF-κB in human chondrocytes. In Vitro Cell.Dev.Biol.-Animal 48, 43–53 (2012). https://doi.org/10.1007/s11626-011-9475-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11626-011-9475-7

Keywords

Navigation